A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.

If the vaccine is effective in a late-stage trial, it would be “paradigm-shifting,” one expert said.

Dal congresso mondiale di oncologia ASCO in corso a Chicago arriva una importante conferma sull'efficacia del vaccino a mRna contro il melanoma, la cui sperimentazione è iniziata…

A doctor breaks down a new study on how mRNA vaccines in melanoma research could transform treatment and survival for cancer patients

Adjuvant approach will need confirmation from ongoing phase III trial, says expert